Literature DB >> 3353129

Immunity to coccidiosis: adoptive transfer in NIH mice challenged with Eimeria vermiformis.

M E Rose1, D Wakelin, H S Joysey, P Hesketh.   

Abstract

The development of a reliable model for the adoptive transfer of immunity to coccidiosis (infection with Eimeria vermiformis in NIH mice) is described. More than 10(8) of a mixture of spleen and mesenteric lymph node (MLN) cells, given either intravenously or intraperitoneally, were required to transfer a significant degree of protection. Dividing cells, present in the donors at 10 or 14 days after priming, but not at 5 or 19 days, were shown to be the effectors. When examined separately, MLN cells were found to be superior to spleen cells, and the injection of as few as 5 x 10(7) was capable of substantially reducing the oocyst output from a challenge inoculum. The recipients of cells from primed mice had earlier, and sometimes higher, titres of specific antibodies in the serum but, overall, there was no correlation between these titres and protection. Further characterization of the cells responsible for adoptively transferring immunity to this infection should now be possible.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3353129     DOI: 10.1111/j.1365-3024.1988.tb00203.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  16 in total

1.  Gamma interferon controls Eimeria vermiformis primary infection in BALB/c mice.

Authors:  M E Rose; D Wakelin; P Hesketh
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

2.  An alphabeta T-cell-independent immunoprotective response towards gut coccidia is supported by gammadelta cells.

Authors:  A L Smith; A C Hayday
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

3.  T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium.

Authors:  S J Roberts; A L Smith; A B West; L Wen; R C Findly; M J Owen; A C Hayday
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

4.  Multi-epitope recombinant vaccine induces immunoprotection against mixed infection of Eimeria spp.

Authors:  Jun Ding; Weifeng Qian; Qun Liu; Qiaorong Liu
Journal:  Parasitol Res       Date:  2011-12-27       Impact factor: 2.289

5.  Treatment of mice with the anticoccidial drug Toltrazuril does not interfere with the development of a specific cellular intestinal immune response to Eimeria falciformis.

Authors:  Svenja Steinfelder; Richard Lucius; Gisela Greif; Thomas Pogonka
Journal:  Parasitol Res       Date:  2005-09-15       Impact factor: 2.289

6.  Eimeria bovis infection enhances adhesion of peripheral blood mononuclear cells to and their transmigration through an infected bovine endothelial cell monolayer in vitro.

Authors:  Anja Taubert; Horst Zahner; Carlos Hermosilla
Journal:  Parasitol Res       Date:  2007-04-13       Impact factor: 2.289

Review 7.  Porcine isosporosis: infection dynamics, pathophysiology and immunology of experimental infections.

Authors:  Hanna L Worliczek; Marc Buggelsheim; Armin Saalmüller; Anja Joachim
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

8.  Immunization of chickens with live Escherichia coli expressing Eimeria acervulina merozoite recombinant antigen induces partial protection against coccidiosis.

Authors:  K S Kim; M C Jenkins; H S Lillehoj
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

9.  Immunization against experimental coccidiosis produces contrasting results in inbred mice of differing susceptibility to infection.

Authors:  M E Rose; P Hesketh; D Wakelin
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Intestinal changes associated with expression of immunity to challenge with Eimeria vermiformis.

Authors:  M E Rose; B J Millard; P Hesketh
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.